🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Metabolic dysfunction-associated steatotic liver disease (MASLD) is current...
Status
Active Not Recruiting
Location
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica
Start Date
2026-01-29
Trial ID
NCT07775716
Atrial fibrillation (AF) is the most common sustained heart rhythm abnormal...
Status
Completed
Location
Barts Heart Centre
Start Date
2016-10
Trial ID
NCT02950844
Treatments Being Tested
Our AIMING project comprises four core work packages (WPs): WP1. Nation-lev...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-10
Trial ID
NCT06971471
Treatments Being Tested
Our GAIN project comprises four core work packages (WPs): WP1. Nation-level...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06-10
Trial ID
NCT06275997
Treatments Being Tested
Participants will take part in both a passive and active emotion recognitio...
Status
Completed
Location
Sonova AG
Start Date
2019-04-08
Trial ID
NCT03992963
Treatments Being Tested
Pulmonary vein isolation (PVI) is still considered the cornerstone of cathe...
Status
Unknown
Location
Centro Nacional de Investigaciones Cardiovasculares (CNIC)
Start Date
2021-12-01
Trial ID
NCT05169320
The purpose of this study is to improve control of myoelectrically-controll...
Status
Recruiting
Location
University of Utah
Start Date
2017-03-01
Trial ID
NCT05509101
Treatments Being Tested
Atrial fibrillation (AF) is the most common sustained heart rhythm abnormal...
Status
Completed
Location
Barts Heart Centre
Start Date
2016-10
Trial ID
NCT06335446
Treatments Being Tested
Exergames have demonstrated potential as effective interventions for promot...
Status
Completed
Location
Hongqiao Community
Start Date
2024-01-01
Trial ID
NCT06950528
Treatments Being Tested